CHARLOTTE, N.C., Nov. 8, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (NasdaqCM:CHTP - News) announced that it has completed its previously announced registered direct offering of approximately 7.4 million shares of common stock at a price $6.62 per share for gross proceeds of $48.9 million.
